Jérémy Guehennec

Preclinical Efficacy of the MDM2 Inhibitor RG7112 in <i>MDM2</i> -Amplified and <i>TP53</i> Wild-type Glioblastomas

Maïté Verreault, Charlotte Schmitt, Lauriane Goldwirt et al. · Clinical Cancer Research · 2015 · 112 citations · Full text

Medicine, Oncology, Pharmacology +15

Temporary blood–brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma

Antonin Dréan, Nolwenn Lemaire, Guillaume Bouchoux et al. · Journal of Neuro-Oncology · 2019 · 89 citations

Medicine, Oncology, Pharmacology +16

ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma

Antonin Dréan, Shai Rosenberg, François‐Xavier Lejeune et al. · Journal of Neuro-Oncology · 2018 · 53 citations

Medicine, Molecular Biology, Oncology +12

Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors

Shai Rosenberg, Maïté Verreault, Charlotte Schmitt et al. · Neuro-Oncology · 2016 · 48 citations · Full text

Medicine, Molecular Biology, Oncology +17

Identification of growth hormone receptor as a relevant target for precision medicine in low‐EGFR expressing glioblastoma

Maïté Verreault, Irma Segoviano Vilchis, Shai Rosenberg et al. · Clinical and Translational Medicine · 2022 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17